↓ Skip to main content

Dove Medical Press

Profile of Margetuximab: Evidence to Date in the Targeted Treatment of Metastatic HER2-positive Breast Cancer

Overview of attention for article published in OncoTargets and therapy, April 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (59th percentile)
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

patent
1 patent

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
16 Mendeley